- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.40 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.3: 8 residues within 4Å:- Chain B: K.35, E.181, V.224, N.232, N.346, V.414, S.415
- Ligands: NAG.33
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.18: 7 residues within 4Å:- Chain I: K.35, V.224, N.232, N.346, V.414, S.415
- Ligands: NAG-NAG.22
No protein-ligand interaction detected (PLIP)- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.4: 4 residues within 4Å:- Chain B: N.246, I.247, T.248, N.249
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.9: 8 residues within 4Å:- Chain G: K.35, E.181, V.224, N.232, N.346, V.414, S.415
- Ligands: NAG-NAG.14
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:K.35
NAG-NAG-BMA.12: 4 residues within 4Å:- Chain G: T.267, H.299, N.301, V.383
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.20: 3 residues within 4Å:- Chain I: T.267, H.299, N.301
No protein-ligand interaction detected (PLIP)- 29 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.23: 1 residues within 4Å:- Chain A: N.95
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain A: R.101, N.102, L.103, S.104, E.105
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain A: N.121
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: S.12
- Chain B: E.57, N.58
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain B: Q.100, F.121, N.122, K.131
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: N.265, S.303
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.271, I.292
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain B: N.308
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain B: N.324
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain B: N.361
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain B: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN.3
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.95
Ligand excluded by PLIPNAG.35: 5 residues within 4Å:- Chain C: R.101, N.102, L.103, S.104, E.105
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.121
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain F: N.95
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain F: R.101, N.102, L.103, S.104, E.105
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain F: N.121
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: S.12
- Chain G: E.57, N.58
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain G: Q.263, N.265, S.303, R.412
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain G: N.308
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain G: N.324
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain G: S.357, N.361
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain F: S.12
- Chain I: E.57, N.58
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain I: Q.100, F.121, N.122, K.131
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain I: Q.263, N.265, R.412
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain I: N.271, I.292
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain I: N.308
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain I: N.324
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain I: S.357, N.361
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escolano, A. et al., Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature (2019)
- Release Date
- 2019-06-12
- Peptides
- RC1 variant of HIV-1 Env glycoprotein gp41: ACF
RC1 variant of HIV-1 Env glycoprotein gp120: BGI
Ab275MUR antibody Fab heavy chain: DHJ
Ab275MUR antibody Fab light chain: EKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CF
FB
BG
GI
ID
DH
HJ
JE
EK
KL
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.40 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 29 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escolano, A. et al., Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature (2019)
- Release Date
- 2019-06-12
- Peptides
- RC1 variant of HIV-1 Env glycoprotein gp41: ACF
RC1 variant of HIV-1 Env glycoprotein gp120: BGI
Ab275MUR antibody Fab heavy chain: DHJ
Ab275MUR antibody Fab light chain: EKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CF
FB
BG
GI
ID
DH
HJ
JE
EK
KL
L